Impact of Prophylactic Antibiotics in Ischemic Stroke Patients on Reduction of Hospital Stay.
Article Sidebar
Main Article Content
Abstract
Background: Ischemic stroke is a leading cause of morbidity and mortality, with post-stroke infections significantly impacting patient outcomes. The use of prophylactic antibiotics to prevent these infections and reduce hospital stay durations has been a subject of debate in the medical community.
Objective: This study aims to evaluate the impact of prophylactic antibiotic administration on the length of hospital stays in ischemic stroke patients.
Methods: Conducted at the Combined Military Hospital, Peshawar, this randomized control trial involved 115 patients, divided into two groups. Group 1 (55 patients) received prophylactic ceftriaxone, while Group 2 (60 patients) did not receive antibiotics. Inclusion criteria were a Glasgow Coma Scale (GCS) score 13 and above, with no pre-existing conditions necessitating antibiotics or complications from the stroke. The primary outcome was the duration of hospital stay.
Results: Group 1 had an average hospital stay of 6.65 days (SD: 2.06 days), while Group 2 had an average of 6.81 days (SD: 1.98 days). The P value of 0.677 indicated no statistically significant difference in hospital stay durations between the groups. Both groups had similar age and GCS score distributions.
Conclusion: The administration of prophylactic antibiotics to ischemic stroke patients did not significantly reduce hospital stay durations. Given the risks associated with antibiotic resistance and side effects, a patient-specific approach to prophylactic antibiotic use is recommended. Future research should focus on identifying specific patient subgroups that may benefit from prophylactic antibiotics and optimal timing for their administration.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Rashid MH, Kabir A, Waris MU, Salman U, Zain S. Role of prophylactic antibiotics in critical care of stroke patients-a preventive approach to post-stroke infections? Cureus. 2020;12(3).
Westendorp WF, Vermeij J-D, Smith CJ, Kishore AK, Hodsoll J, Kalra L, et al. Preventive antibiotic therapy in acute stroke patients: A systematic review and meta-analysis of individual patient data of randomized controlled trials. European stroke journal. 2021;6(4):385-94.
Vermeij J-D, Westendorp WF, van de Beek D, Nederkoorn PJ. Post-stroke infections and preventive antibiotics in stroke: update of clinical evidence. International Journal of Stroke. 2018;13(9):913-20.
Westendorp WF, Dames C, Nederkoorn PJ, Meisel A. Immunodepression, infections, and functional outcome in ischemic stroke. Stroke. 2022;53(5):1438-48.
Wang Q, Wu ZY, Tang HL, Yi ZM, Zhai SD. The efficacy and safety of prophylactic antibiotics for post‐acute stroke infection: A systematic review and meta‐analysis. British Journal of Clinical Pharmacology. 2023;89(3):946-55.
Badve MS, Zhou Z, Anderson CS, Hackett ML. Effectiveness and safety of antibiotics for preventing pneumonia and improving outcome after acute stroke: systematic review and meta-analysis. Journal of Stroke and Cerebrovascular Diseases. 2018;27(11):3137-47.
Jitpratoom P, Boonyasiri A. Determinants of urinary tract infection in hospitalized patients with acute ischemic stroke. BMC neurology. 2023;23(1):251.
Karlinski MA, Bembenek JP, Baranowska A, Kurkowska-Jastrzebska I, Czlonkowska A. Infections diagnosed after admission to a stroke unit and their impact on hospital mortality in Poland from 1995 to 2015. Journal of Stroke and Cerebrovascular Diseases. 2018;27(7):1775-82.
Faheem SM, Gohar UF, Riaz S. 1. Recent developments in methicillin-resistant Staphylococcus aureus (MRSA) management and potential antimicrobial alternatives to combat the antibiotic resistance challenge: A review. Pure and Applied Biology (PAB). 2021;11(2):353-85.
Khan SK, Bokhari U, Khan SA, Shoaib U, Rana ZH, Omer Z. Original Article Patient satisfaction regarding Emergency Department services at Combined Military Hospital (CMH) Lahore–A cross-sectional study: Sehar Khauteja Khan, Uswah Bokhari, Shahmir Ahmad Khan, Uswah Shoaib, Rana Zaid Haris, Zainab Omer. Journal of Akhtar Saeed Medical & Dental College. 2023;4(4):163-71.
Jalil A, Masood S, Ain Q, Andleeb S, Dudley EG, Adnan F. High resistance of fluoroquinolone and macrolide reported in avian pathogenic Escherichia coli isolates from the humid subtropical regions of Pakistan. Journal of Global Antimicrobial Resistance. 2023;33:5-17.
Morassi M, Bagatto D, Cobelli M, D’Agostini S, Gigli GL, Bnà C, et al. Stroke in patients with SARS-CoV-2 infection: case series. Journal of neurology. 2020;267:2185-92.
Mizu D, Matsuoka Y, Huh J-Y, Kamitani Y, Fujiwara S, Ariyoshi K. The necessity of lumbar puncture in adult emergency patients with fever-associated seizures. The American Journal of Emergency Medicine. 2022;58:120-5.
Naveen Kumar M. A Comparative study of Single Dose Preoperative Ceftriaxone and Routine Conventional Postoperative Prophylaxis in Elective General Surgical Cases: Coimbatore Medical College, Coimbatore; 2020.
Izadi M, Dadsetan B, Najafi Z, Jafari S, Mazaheri E, Dadras O, et al. Levofloxacin versus ceftriaxone and azithromycin combination in the treatment of community acquired pneumonia in hospitalized patients. Recent patents on anti-infective drug discovery. 2018;13(3):228-39.
Grégoire M, Berteau F, Bellouard R, Lebastard Q, Aubert P, Gonzales J, et al. A murine model to study the gut bacteria parameters during complex antibiotics like cefotaxime and ceftriaxone treatment. Computational and Structural Biotechnology Journal. 2021;19:1423-30.
Ghelani DP, Kim HA, Zhang SR, Drummond GR, Sobey CG, De Silva TM. Ischemic stroke and infection: A brief update on mechanisms and potential therapies. Biochemical pharmacology. 2021;193:114768.
Han X, Huang J, Jia X, Peng L, Yan K, Zan X, et al. Preventive antibiotics for poststroke infection in patients with acute stroke: A systematic review and meta-analysis. The neurologist. 2018;23(2):35-42.
Zhang X, Zhang X-F, Wang L, Guo D-Y, Zhang J-M, Chen Y-G, et al. Analysis of clinical efficacy of traditional chinese medicine in recovery stage of stroke: a systematic review and meta-analysis. Cardiovascular therapeutics. 2020;2020.
Vermeij JD, Westendorp WF, Dippel DW, van de Beek D, Nederkoorn PJ. Antibiotic therapy for preventing infections in people with acute stroke. Cochrane Database of Systematic Reviews. 2018(1).
Pendlebury ST, Rothwell PM. Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study. The Lancet Neurology. 2019;18(3):248-58.
Brown RJ, Raabe M, McCullough LD, Zhu L, Chokshi RV. Clostridium difficile infection does not impact outcomes in stroke patients. The Neurologist. 2022;27(3):125-9.
Lord AS, Nicholson J, Lewis A. Infection prevention in the neurointensive care unit: a systematic review. Neurocritical care. 2019;31:196-210.
Hanberg P. Plasma, Subcutaneous Adipose Tissue, Vertebral Cancellous Bone and Intervertebral Disc Pharmacokinetics of Cefuroxime.
van Velzen TJ, Kuhrij LS, Westendorp WF, van de Beek D, Nederkoorn PJ. Prevalence, predictors and outcome of carotid stenosis: a sub study in the Preventive Antibiotics in Stroke Study (PASS). BMC neurology. 2021;21(1):1-6.
Maida CD, Norrito RL, Daidone M, Tuttolomondo A, Pinto A. Neuroinflammatory mechanisms in ischemic stroke: focus on cardioembolic stroke, background, and therapeutic approaches. International journal of molecular sciences. 2020;21(18):6454.